Category: St. Jude Medical
Researchers say that devices used to close off the heart's left atrial appendage appear as good as anti-coagulation drugs for treating certain patients with an increased risk of having a stroke.
New clinical data continues to suggest that left atrial appendage occlusion devices may pose an improvement over warfarin drug regimens for treating patients at increased risk of stroke, researchers reported today.
St. Jude Medical's quadripolar pacing leads show better survival rates in the 1st head-to-head study comparing them to bipolar leads, researchers say.
St. Jude Medical reports a new Dept. of Justice probe into allegations that the company paid illegal kickbacks and encouraged doctors to submit False Claims for its cardiac devices.
Here's a look at some of the top legal news stories for medical device companies this week.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
A federal appeals court upholds the U.S. Patent & Trademark Office's decision to deny St. Jude Medical's bid for a review of a fractional flow reserve patent.
St. Jude Medical meets Wall Street's expectations for its 1st quarter of 2014 with moderate sales growth across its product lines, but shares take a downward turn in morning trading.
Minnesota medtech titan St. Jude Medical (NYSE:STJ) lost a few points on Wall Street today after posting 1st quarter earnings a penny above analysts' consensus estimate.